Home > Understanding Breast Cancer > Treatment > Common Breast Cancers > Recommended Treatments for Ductal Carcinoma in Situ

  


Recommended Treatments for Ductal Carcinoma in Situ

  

 

Breast Surgery
PDF, 136KB

 

Radiation Therapy
PDF, 124KB

 

Tamoxifen
PDF, 137KB

Treatment for ductal carcinoma in situ (DCIS) usually involves surgery with or without radiation therapy. After surgery and radiation, some women may take tamoxifen.

Surgery

The first step in treating DCIS is surgery to remove the abnormal tissue in the breast. Depending on how far the DCIS has spread within the ducts, surgery can be either mastectomy or lumpectomy.    

If DCIS has spread throughout the ducts, affecting a large part of the breast, you will need a total (simple) mastectomy. In a total mastectomy, the surgeon removes the entire breast but no other tissue or lymph nodes.  

If there is little spread of DCIS within the ducts, a choice can be made between mastectomy and lumpectomy. With lumpectomy, the surgeon removes only the abnormal tissue, but the rest of the breast is left intact. In most cases, it does not include the removal of any lymph nodes.   

Most women in the United States with DCIS choose treatment with lumpectomy followed by radiation therapy [98-99].  

Learn more about mastectomy and lumpectomy.

Radiation therapy

Radiation therapy is not given to women who are treated with mastectomy for DCIS.  

Lumpectomy for DCIS is usually followed by radiation therapy to lower the risk of invasive breast cancer and DCIS recurrence [100-105]. Select women with smaller, lower grade DCIS and clean surgical margins, may be candidates for lumpectomy without radiation therapy [100,106].  

Overall survival appears to be similar for women with DCIS who have lumpectomy with or without radiation therapy [102-103].  

Learn more about radiation therapy.

  

For a summary of research studies on lumpectomy plus radiation therapy in the treatment of DCIS, visit the Breast Cancer Research section.

Hormone therapy with tamoxifen

The National Comprehensive Cancer Network (NCCN) recommends women who are treated with lumpectomy plus radiation therapy for estrogen receptor-positive (ER+) DCIS consider taking tamoxifen for five years [100]. Studies have shown tamoxifen can lower the risk of a recurrence of DCIS as well as the risk of getting invasive cancer in both the affected breast and the opposite breast [104-105,107].

Because women who have a mastectomy for DCIS have an excellent prognosis with a low risk of recurrence, the benefit of tamoxifen is likely very small and such treatment is not usually recommended. 

Learn more about tamoxifen.   

Learn more about factors that affect treatment options

 

For a summary of research studies on tamoxifen as a treatment for DCIS, visit the Breast Cancer Research section. 

 

Komen Perspectives 

 Read our perspective on DCIS (March 2013).*  

 

For more information on treatment for DCIS, visit the National Comprehensive Cancer Network (NCCN) or the American Society for Clinical Oncology (ASCO).

*Please note, the information provided within Komen Perspectives articles is only current as of the date of posting. Therefore, some information may be out of date at this time.  

Updated 04/19/13

previous  Ductal Carcinoma in Situ  
 Risk of Developing Invasive Cancer after Ductal Carcinoma in Situ next 

Related Links

Visited by Others

Komen Videos